Position in NVO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$29,480,776
+$24,025,677 QoQ
Shares Held
802,198
+648.2% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,449 | $30,524,296 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
128,157 | $7,384,406 | |
| 3 | BIIB |
Biogen Inc.
|
20,649 | $4,461,422 | |
| 4 | PFE |
Pfizer Inc
|
173,689 | $4,182,431 | |
| 5 | AMGN |
Amgen Inc
|
8,927 | $3,232,645 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,216 | $2,933,109 | |
| 7 | NVS |
Novartis AG
|
9,740 | $1,526,452 | |
| 8 | AZN |
Astrazeneca PLC
|
7,754 | $1,470,313 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,480,776 | 802,198 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $5,455,099 | 107,215 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $15,713,103 | 283,170 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $19,225,037 | 278,543 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $21,837,838 | 314,485 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,817,550 | 56,005 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $7,906,248 | 66,400 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||